MyMedR

Displaying all 4 publications

Abstract:

Sort:

Methanol production and purification via membrane-based technology: Recent advancements, challenges and the way forward

Qadeer K, Al-Hinai A, Chuah LF, Sial NR, Al-Muhtaseb AH, Al-Abri R, et al.

Chemosphere, 2023 Sep;335:139007.
PMID: 37253401 DOI: 10.1016/j.chemosphere.2023.139007

Industrial revolution on the back of fossil fuels has costed humanity higher temperatures on the planet due to ever-growing concentration of carbon dioxide emissions in Earth's atmosphere. To tackle global warming demand for renewable energy sources continues to increase. Along renewables, there has been a growing interest in converting carbon dioxide to methanol, which can be used as a fuel or a feedstock for producing chemicals. The current review study provides a comprehensive overview of the recent advancements, challenges and future prospects of methanol production and purification via membrane-based technology. Traditional downstream processes for methanol production such as distillation and absorption have several drawbacks, including high energy consumption and environmental concerns. In comparison to conventional technologies, membrane-based separation techniques have emerged as a promising alternative for producing and purifying methanol. The review highlights recent developments in membrane-based methanol production and purification technology, including using novel membrane materials such as ceramic, polymeric and mixed matrix membranes. Integrating photocatalytic processes with membrane separation has been investigated to improve the conversion of carbon dioxide to methanol. Despite the potential benefits of membrane-based systems, several challenges need to be addressed. Membrane fouling and scaling are significant issues that can reduce the efficiency and lifespan of the membranes. The cost-effectiveness of membrane-based systems compared to traditional methods is a critical consideration that must be evaluated. In conclusion, the review provides insights into the current state of membrane-based technology for methanol production and purification and identifies areas for future research. The development of high-performance membranes and the optimization of membrane-based processes are crucial for improving the efficiency and cost-effectiveness of this technology and for advancing the goal of sustainable energy production.
Fulltext Expert Opinion on Biological Treatment of Chronic Rhinosinusitis with Nasal Polyps in the Gulf Region

Al-Ahmad M, Alsaleh S, Al-Reefy H, Al Abduwani J, Nasr I, Al Abri R, et al.

J Asthma Allergy, 2022;15:1-12.
PMID: 35018101 DOI: 10.2147/JAA.S321017

Chronic rhinosinusitis (CRS) is defined as the inflammation of nose and paranasal sinuses, affecting the patients' quality of life and productivity. Chronic rhinosinusitis with nasal polyps (CRSwNP) is a principal clinical entity confirmed by the existence of chronic sinonasal inflammation and is characterized by anterior or posterior rhinorrhea, nasal congestion, hyposmia and/or facial pressure or facial pain. Several epidemiologic studies have revealed wide variations in the incidence of CRS among regions globally ranging from 4.6% to 12%. The Gulf countries are also witnessing an unprecedented burden of CRSwNP. According to the current clinical guidelines, glucocorticosteroids and antibiotics are the principal pharmacotherapeutic approaches. Endoscopic sinus surgery is recommended for those who have failed maximal pharmacotherapy. Recently, biologics are considered as an alternative best approach due to the complications associated with medical therapy and surgery. However, precise data on the clinical position of biologic agents in the management of CRSwNP in the Gulf region is not available. The present review article addresses the current diagnostic and management approaches for CRSwNP and also emphasizes the role of emerging biologics in the current treatment strategies for CRSwNP in the Gulf region. Further, a consensus protocol was convened to rationalize the guideline recommendations, strategize the best practices with biologics, and develop clinical practice guidelines for all primary-care specialists in the Gulf region. The consensus-based report will be a useful reference tool for primary-care physicians in primary-healthcare settings, regarding the appropriate time for the initiation of biological treatment in the Gulf region.
Fulltext Assessment of chronic rhinosinusitis with nasal polyps: Development of the Nasal Polyp Patient Assessment Scoring Sheet tool

Alsaleh S, Kamal N, Hopkins C, Al Rand H, Marglani OA, Alterki A, et al.

Laryngoscope Investig Otolaryngol, 2024 Jun;9(3):e1277.
PMID: 38803462 DOI: 10.1002/lio2.1277

BACKGROUND: Chronic rhinosinusitis (CRS) is a heterogeneous disorder with a wide range of validated subjective and objective assessment tools to assess disease severity. However, a comprehensive and easy-to-use tool that integrates these measures for determining disease severity and response to treatment is still obscure. The objective of this study was to develop a standardized assessment tool that facilitates diagnosis, uniform patient monitoring, and comparison of treatment outcomes between different centers both in routine clinical practice and in research.
METHODS: To develop this tool, published literature on assessment tools was searched on various databases. A panel of 12 steering committee members conducted an advisory board meeting to review the findings. Specific outcome measures to be included in a comprehensive assessment tool and follow-up sheet were then collated following consensus approval from the panel. The tool was further validated for content and revised with expert recommendations to arrive at the finalized Nasal Polyp Patient Assessment Scoring Sheet (N-PASS) tool.
RESULTS: The N-PASS tool was developed by integrating the subjective and objective measures for CRS assessment. Based on expert opinions, N-PASS was revised to be used as an easy-to-use guidance tool that captures patient-reported and physician-assessed components for comprehensively assessing disease status and response to treatment.
CONCLUSION: The N-PASS tool can be used to aid in the diagnosis and management of CRS cases with nasal polyps. The tool would also aid in improved monitoring of patients and pave the way for an international disease registry.
LEVEL OF EVIDENCE: Oxford Level 3.
Fulltext Novel Multidisciplinary Salivary Gland Society (MSGS) Questionnaire: An International Consensus

Buchholzer S, Faure F, Tcheremissinoff L, Herrmann FR, Lombardi T, Ng SK, et al.

Laryngoscope, 2022 02;132(2):322-331.
PMID: 34236085 DOI: 10.1002/lary.29731

OBJECTIVES: First, establishment and validation of a novel questionnaire documenting the burden of xerostomia and sialadenitis symptoms, including quality of life. Second, to compare two versions regarding the answering scale (proposed developed answers Q3 vs. 0-10 visual analogue scale Q10) of our newly developed questionnaire, in order to evaluate their comprehension by patients and their reproducibility in time.
STUDY DESIGN: The study is a systematic review regarding the evaluation of the existing questionnaire and a cohort study regarding the validation of our new MSGS questionnaire.
MATERIALS AND METHODS: A Multidisciplinary Salivary Gland Society (MSGS) questionnaire consisting of 20 questions and two scoring systems was developed to quantify symptoms of dry mouth and sialadenitis. Validation of the questionnaire was carried out on 199 patients with salivary pathologies (digestive, nasal, or age-related xerostomia, post radiation therapy, post radioiodine therapy, Sjögren's syndrome, IgG4 disease, recurrent juvenile parotitis, stones, and strictures) and a control group of 66 healthy volunteers. The coherence of the questionnaire's items, its reliability to distinguish patients from healthy volunteers, its comparison with unstimulated sialometry, and the time to fill both versions were assessed.
RESULTS: The novel MSGS questionnaire showed good internal coherence of the items, indicating its pertinence: the scale reliability coefficients amounted to a Cronbach's alpha of 0.92 for Q10 and 0.90 for Q3. The time to complete Q3 and Q10 amounted, respectively, to 5.23 min (±2.3 min) and 5.65 min (±2.64 min) for patients and to 3.94 min (±3.94 min) and 3.75 min (±2.11 min) for healthy volunteers. The difference between Q3 and Q10 was not significant.
CONCLUSION: We present a novel self-administered questionnaire quantifying xerostomia and non-tumoral salivary gland pathologies. We recommend the use of the Q10 version, as its scale type is well known in the literature and it translation for international use will be more accurate. Laryngoscope, 132:322-331, 2022.